8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)
Published . Updated .
Filed: 2026-10-15 AccNo: 0001193125-26-422992 Size: 460 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Directly affected
- ALXO Alx Oncology Holdings
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-15 AccNo: 0001193125-26-422992 Size: 460 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Alx Oncology Holdings (ALXO)
Since the first closing price after “8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer),” Alx Oncology Holdings (ALXO) is +7.51%. The S&P 500 fund (SPY) is +0.43% over the same days, a +7.08% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Alx Oncology Holdings (ALXO) | that day | +6.47% | final price |
| Alx Oncology Holdings (ALXO) | the next day | +13.93% | final price |
| Alx Oncology Holdings (ALXO) | two days later | +11.94% | still updating |
| Alx Oncology Holdings (ALXO) | three days earlier | -2.48% | final price |
| Alx Oncology Holdings (ALXO) | five days earlier | +25.37% | final price |
| GLD | that day | -0.17% | final price |
| GLD | the next day | -0.79% | final price |
| GLD | two days later | -1.15% | still updating |
| GLD | three days earlier | -0.27% | final price |
| GLD | five days earlier | +0.50% | final price |
| QQQ | that day | -2.52% | final price |
| QQQ | the next day | -1.36% | final price |
| QQQ | two days later | -1.67% | still updating |
| QQQ | three days earlier | +2.12% | final price |
| QQQ | five days earlier | +3.17% | final price |
| SPY | that day | -1.09% | final price |
| SPY | the next day | -0.67% | final price |
| SPY | two days later | -0.49% | still updating |
| SPY | three days earlier | +0.81% | final price |
| SPY | five days earlier | +0.87% | final price |
| TLT | that day | +0.06% | final price |
| TLT | the next day | -0.66% | final price |
| TLT | two days later | +0.16% | still updating |
| TLT | three days earlier | -2.05% | final price |
| TLT | five days earlier | -2.54% | final price |
Who gains and who loses around Alx Oncology Holdings (ALXO)
Companies tied to this story
- ALXO Alx Oncology Holdings
For “8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer),” Alx Oncology Holdings (ALXO) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ALXO
How “8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)” reaches Alx Oncology Holdings (ALXO)
Alx Oncology Holdings (ALXO) is the company in “8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer),” the 15 Oct 2026 this story story.
The link for Alx Oncology Holdings (ALXO) is this: SEC 8-K filing -> direct issuer disclosure -> ALXO
Dates in the story, and the Alx Oncology Holdings (ALXO) price range
ALXO traded between 0.87 and 2.09 across 13 sessions. The latest close on file is 1.15.
What the saved facts support for Alx Oncology Holdings (ALXO)
44 out of 100Price not final
“8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)” scores 44 out of 100. The score uses 1 sources, a +14.60% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.